Home Cart Sign in  
Chemical Structure| 1180676-32-7 Chemical Structure| 1180676-32-7

Structure of PS-48
CAS No.: 1180676-32-7

Chemical Structure| 1180676-32-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PS48 is a PDK1 activator with an AC50 of 8 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PS-48

CAS No. :1180676-32-7
Formula : C17H15ClO2
M.W : 286.75
SMILES Code : O=C(O)/C=C(C1=CC=CC=C1)/CCC2=CC=C(Cl)C=C2
MDL No. :MFCD17215962
InChI Key :LLJYFDRQFPQGNY-QINSGFPZSA-N
Pubchem ID :44141940

Safety of PS-48

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of PS-48

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse fibroblast (Mh cell line) 0.5, 1, 2, 5 µM 48 hours To test the efficacy of antisense oligonucleotides (PMO1-3) targeting Postn exon 17 in reducing TGF-β1-induced e17+ mPostn mRNA expression. All PMOs significantly reduced e17+ mPostn expression, with PMO3 showing the highest efficacy at the lowest dose (0.5 µM). PMC11172600
Human renal mesangial cells (HRMCs) 5 μmol/L 72 hours PS48 reversed the inhibitory effect of TP on HRMCs proliferation PMC5666525
MC3T3-E1 cells 5 µM 14 days PS48 promoted the osteogenic ability of MC3T3-E1 cells, increasing the expression of PDK1 and osteogenic markers Runx2, OCN, and ALP. PMC6997475
Porcine fetal fibroblasts 10 µM 7 days To assess the effect of drug combination on mitochondrial function and autophagy, results showed that the drug combination decreased mitochondrial membrane potential and increased the number of autolysosomes. PMC6603033

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse (D2.mdx model) Duchenne muscular dystrophy model Intraperitoneal injection 10 mg/kg Weekly for 10 weeks To evaluate the therapeutic effect of PMO3 on fibrosis in D2.mdx mice. Results showed significant reduction in e17+ mPostn mRNA/protein expression and collagen deposition in diaphragm, with grip strength normalized to wild-type levels. PMC11172600
Mice D2.mdx mouse model Tail vein injection 4×10^9 mg/mouse Single injection, 8 weeks duration Evaluate the efficacy of AAV8-MD1 in D2.mdx mice, showing significant improvement in muscle function and pathology with microdystrophin expression PMC10179398
C57BL/6J mice Glucocorticoid-induced osteoporosis model Intraperitoneal injection 10 mg/kg bodyweight Daily injection for 21 days PS48 could maintain the bone mass of dexamethasone-treated mice, increasing femur BMD and BV/TV. PMC6997475

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.49mL

0.70mL

0.35mL

17.44mL

3.49mL

1.74mL

34.87mL

6.97mL

3.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories